About
Technology
Issues
FAQ
Links
Official Page
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.